Vivos (RDGL) Assets Average (2011 - 2025)
Vivos (RDGL) reported Assets Average of $2.1 million for Q4 2025, up 19.7% on a YoY basis from $1.7 million in Q4 2024, and down 17.91% sequentially from $2.5 million in Q3 2025.
Vivos (RDGL) Assets Average (2011 - 2025) Analysis & Trends
Vivos (RDGL) has 15 years of Assets Average data on file, last reported at $2.1 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 19.7% year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.1 million (up 19.7% YoY), and the FY2025 full-year result was $2.1 million, up 6.7% from the prior year.
- Assets Average retreated to $2.1 million in Q4 2025, from $2.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $3.0 million in Q2 2025 to a low of $1.2 million in Q2 2022.
- A 5-year average of $1.9 million and a median of $1.7 million in 2021 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 1096.37% in 2021 and plunged 49.16% in 2022, its largest moves.
- Tracing RDGL's Assets Average over 5 years: stood at $1.8 million in 2021, then rose by 3.01% to $1.9 million in 2022, then slipped by 16.16% to $1.6 million in 2023, then advanced by 9.48% to $1.7 million in 2024, then grew by 19.7% to $2.1 million in 2025.
- Business Quant data shows RDGL's Assets Average at $2.1 million in Q4 2025, $2.5 million in Q3 2025, and $3.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 6.49 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 37.02 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 10.57 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 31.64 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | 3.04 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.58 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 2.14 Mn |
| Jun 30, 2021 | 2.38 Mn |
| Mar 31, 2021 | 1.73 Mn |